|
David C. Tiemeier Ph.D. has been a director of the Company since October 2007. He is currently serving as Deputy Director of UChicagoTech the University of Chicago’s Office of Technology and Intellectual Property. Previously Dr. Tiemeier pursued postdoctoral studies in molecular genetics at the National Institutes of Health before joining the faculty of the University of California Irvine Medical School. He joined Monsanto Co. (NYSE:MON) as the head of Molecular Genetics and continued his career in Monsanto’s pharmaceutical division as Senior Director of Immunoinflammatory and Infectious Diseases and took on roles of increasing responsibility including General Manager of the Global New Business Franchise and Vice President of Global Business Development. He subsequently held senior positions in Pharmacia Corporation and Pfizer Inc. (NYSE:PFE). Following his retirement from Pfizer Dr. Tiemeier held senior management positions with NeoPharm Inc. (Nasdaq:NEOL) Immtech Pharmaceuticals Inc. (Amex:IMM) and Kalypsys Inc. | 